Form 4: DENTSPLY SIRONA CEO's Tax-Related Stock Disposition

DENTSPLY SIRONA Inc. CEO Daniel T. Scavilla reported a disposition of shares to cover tax obligations related to vested equity.

Summary

• Daniel T. Scavilla, President, CEO, Director, and Member of the Board of Directors of DENTSPLY SIRONA Inc. (XRAY), reported a transaction.
• The transaction involved the disposition of 1,194.48 shares of Common Stock on February 24, 2026.
• These shares were withheld to cover taxes related to the vesting of Restricted Stock Units and dividend equivalent units.
• The disposition occurred at a price of $13.14 per share.
• Following this transaction, Daniel T. Scavilla beneficially owns 16,750.066 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine, non-discretionary disposition of shares for tax purposes related to vested equity, which is a common practice for executives.

Negatives

• A reduction in the direct beneficial ownership of common stock by the CEO, albeit for tax purposes.

Future Outlook

No forward-looking statements or guidance were provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider transactions, particularly Form 4 filings detailing tax-related dispositions of equity awards, are common occurrences in the corporate landscape. These events are typically administrative and do not usually reflect a change in management's outlook on the company's performance or future prospects, aligning with standard executive compensation practices across various industries.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine tax-related transaction and does not signal a change in company fundamentals or management's confidence.

Key Dates

Recommendation

This Form 4 filing details a routine, tax-related disposition of shares by the CEO, which is a common administrative event for executives receiving equity compensation. It does not provide any new material information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, as the filing does not alter the fundamental investment thesis for DENTSPLY SIRONA Inc.

Keywords

DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, Stock Disposition, Restricted Stock Units, Tax Withholding, CEO, Daniel T. Scavilla